GlaxoSmithKline (GSK) is one of the world’s largest research based pharmaceutical corporation that discover, develops, manufactures and markets branded health care products. GSK mission is to improve the quality of human life by enabling people to do more, feel better and live longer
2. Contents
Company Introduction
Health Care Portfolio
Influenza Virus
Products
Vaccine Development Process
12/3/2014 GSK - Influenza Virus Vaccine 2
3. GlaxoSmithKline
World largest research based
pharmaceutical corporation
that discover, develops,
manufactures and markets
branded health care products.
2012
Source:http://www.gsk.com/content/dam/gsk/globals/documents/pdf/GSK-Annual-Report-2012.pdf
12/3/2014 GSK - Influenza Virus Vaccine 3
11. Influenza
Influenza (the flu) contagious respiratory disease caused by
influenza viruses.
Affect the respiratory track (nose, throat and lungs).
Symptoms : fever, headache, malaise, cough, sore throat, nasal
congestion and body aches.
10% to 20% of the population is infected with influenza
virus each year
It can cause to severe illness and at times lead to death.
12/3/2014 GSK - Influenza Virus Vaccine 11
12. Types of Influenza Virus
12/3/2014 GSK - Influenza Virus Vaccine 12
Sr.
No
Basis Type A Type B Type C
1 Symptoms Moderate to Severe Mild Mild
2 Age Group All Primarily children All
3 Affect Humans and animal Affects human
only
Affects human
only
4 Divided Subdivided based on
antigenic differences
Not divided into
sub types
Not divided
into sub types
5 Epidemics Widespread Regional Don’t cause
6 Experienced Mostly Less Common
than type A
Rarely
Reported
13. Influenza A Virus
Is subdivide into two distinct large surface glycoprotein's antigens.
H- Haemagglutinin which initiates infection and attachment of
virus to the susceptible cell
N- Neuraminidase which is responsible for release of virus from the
infected cell
Mutations in the antigenic structure of the influenza virus have
resulted in a number of different influenza subtypes and strains
(antigenic drift)
H Type (1-15) and N Type (1-9)
Only H1, H2 and H3 and N1, N2 are found in humans.
Example: H1N1,H2N2,H3N2 etc.
Source: Karl G Nicholson, John M Wood, Maria Zambon, THE LANCET • Vol 362 • November 22, 2003 • www.thelancet.com
12/3/2014 GSK - Influenza Virrus Vaccine 13
16. Types of Influenza Vaccines
Inactivated Vaccine (Killed)
• These type of vaccine are produced by killing the virus with
chemicals, heat or radiation.
• There are three types of inactivated vaccine whole virus, split
virus and subunit vaccine.
• They are generally injected (intramuscular).
Live Attenuated Vaccine
• The vaccine contain a version of weakened strain of virus.
• They are given intranasal.
12/3/2014 GSK - Influenza Virus Vaccine 16
21. Pandemrix
For influenza pandemic (H1N1)
also know as swine flu
Supplied as suspension to be
mixed with emulsion adjuvant
(AS03) before injection
Composition:
• A/California/7/2009 (H1N1)
12/3/2014 GSK - Influenza Virus Vaccine 21
22. GSK Flu Vaccine Development Process
Source: http://www.gsk.com/content/dam/gsk/globals/documents/pdf/GSK-Flu-Vaccine-Production-Process.pdf
12/3/2014 GSK - Influenza Virus Vaccine 22
23. GSK Flu Vaccine Development Process
12/3/2014 GSK - Influenza Virus Vaccine 23
24. GSK Flu Vaccine Development Process
12/3/2014 GSK - Influenza Virus Vaccine 24
25. GSK Flu Vaccine Development Process
12/3/2014 GSK - Influenza Virus Vaccine 25
http://www.authorstream.com/Presentation/aSGuest7771-126796-gsk-presentation-11-7-07-others-misc-ppt-powerpoint/
Headquarters: UK, with additional
operational headquarters in the USA
Global presence: about 160 countries
Primary markets: USA, France, Germany,
UK, Italy and Japan
Employees: approximately 103,000
http://www.gsk.com/about-us/what-we-do.html
Oral care
Nutritional
Total wellness
Skin health
5 multinational companies make up to the 80% of the global market.
Quadrivalent
Provide coverage to 2 influenza A virus strains and 2 influenza B
virus strains
Trivalent
Provide coverage to 2 influenza A virus strains and 1 influenza B
virus strains